Formulary Insights—Powered by Petauri

Here's a list no manufacturer wants to be on — drug classes expected to see new payer restrictions. Some categories may surprise you. But our SMEs have been there before and can ensure your team is ready. A better approach to navigate market access hurdles is available — and it starts with our SME-generated insights. Finally, there is a better way! #marketaccess #biopharma

Newly approved treatments are now approved for hemophilia, UTIs, MacTel, and tenosynovial tumors. Congratulations and gratitude are due to the many colleagues at Springworks, Deciphera Pharmaceuticals, Neurotech Pharmaceuticals, Inc., GSK and Genzyme who made these therapies available to patients, healthcare providers and families who all stand to benefit from their good work! #marketacess #biopharma

Congratulations to Laura Ptaszek, MS on joining Petauri Advisors as our newest Principal of Business Development! Laura is a highly accomplished US Market Access executive with a career that spans biopharma, payers, and non-traditional PBM/Digital Health Tech sectors. With over 25 years in headquarters and customer-facing roles with leading manufacturers such as AbbVie, Allergan, and Novartis, Laura can draw from her direct experience developing and communicating contracting and pricing strategies to US payers that are critical to market access success. Additionally, she has launched dozens of brands to include blockbusters in oncology, immunology, neuroscience, eyecare and rare disease.   She is also an active volunteer with Healthcare Businesswomen’s Association, previously serving as the Metro chapters (NY/NJ) Vice President of Marketing and Fundraising Chair and currently as the Vice President of Corporate Partners for the Southeast region, where she supports biopharma manufacturers from North Carolina to Florida. She is also an active volunteer for the Obesity Action Coalition’s Access to Care Committee as the biopharma expert.   Laura is passionate about improving both the accessibility and affordability of medications for patients, and she excels at connecting with diverse stakeholders across the healthcare ecosystem! She has earned two degrees in healthcare: a Bachelor of Science in Nutrition from Rutgers University, as well as a Master of Science in Healthcare Administration from St. Elizabeth University. Laura currently resides in Sarasota, Florida. Welcome to the team, Laura!

We are so proud to see our payer SMEs continue to thrive as part of Petauri. Shana Gunderson Hua, PharmD and Nancy Pham are generously sharing their expertise via a new article published by Pharmaceutical Executive. #marketacess #biopharma

New therapies approved and new hope on the rise for patients suffering from breast cancer, pain, neurofibromatosis, and tenosynovial giant cell tumors. Congratulations and gratitude are due for AstraZeneca & Daiichi Sankyo US, Vertex Pharmaceuticals, SpringWorks Therapeutics, and Deciphera Pharmaceuticals! May the patients in need gain access and positively respond very soon. #marketaccess #biopharma

Please join us in welcoming Shana Gunderson Hua, PharmD, as our newest Vice President of Value & Access at Formulary Insights—Powered by Petauri! With over 20 years of experience in payer strategy, oncology market access, and biopharma commercialization, Shana specializes in translating complex access challenges into actionable strategies that optimize product uptake, pricing, and reimbursement. Shana spearheaded medical rebate contract negotiations across gene therapies, biosimilars, and value-based agreements while at Cigna Healthcare/Express Scripts by Evernorth. She also led high-impact medical and market access engagements for Genentech with national health plans, PBMs, and GPOs—shaping policy, expanding affordability initiatives, and accelerating access across oncology, rare diseases, retina, and autoimmune conditions. As the founder of Innovative Pharmacy Solutions, LLC, Shana has been at the forefront of oncology market access innovation—helping biopharma manufacturers and healthcare startups optimize revenue streams, implement oncology treatment pathways, enhance formulary adherence, and leverage GPO purchasing strategies to drive affordability and provider adoption.   Shana's deep industry expertise navigating the evolving market access landscape makes her a critical addition to Petauri's impressive roster of market access SMEs. We are excited for Shana to help our biopharma partners accelerate access, remove barriers, and maximize commercial success.   Welcome to the team, Shana! #marketaccess #biopharma

Congratulations to Nancy Pham, the new President Elect of California AMCP. Further evidence that SME-led market access research changes the experience for biopharma. For the most actionable payer insights, work with those who have been there. Choose Formulary Insights—Powered by Petauri! #marketaccess #biopharma

More treatment options for patients and their healthcare providers. Congratulations to AstraZeneca, Daiichi Sankyo US and Vertex Pharmaceuticals for their January approvals to aid the fights against breast cancer and pain... just the most recent examples of biopharma doing good for humankind! #biopharma #marketaccess

Are you ready for a career change that opens the door to greater upward mobility? Are you allowing your current employer's timeline to dictate your ambitions while a high-growth company like Formulary Insights—Powered by Petauri is looking for top talent to join its team today? We are hiring Business Development Principals! If you have a strong biopharma network, a proven track record of success, and the confidence you can drive meaningful business growth, this is your opportunity to take back the reins of your career trajectory. Apply today: https://lnkd.in/dpxkdZzk

Empathy drives understanding and understanding drives business. The Samsung Bioepis' Biosimilar Market Dynamics Report exemplifies how biopharma can demonstrate understanding to payers. Formulary Insights—Powered by Petauri is proudly entering its third year supporting this important reference. We exist to help manufacturers build trust with payers. Let us help your team get to the next level. #marketaccess #biopharma